TP53 and malignant peripheral nerve sheath tumor: Furthermore, we propose that the presence of either SUZ12, EED, or TP53 inactivating mutations or significant aneuploidy serve as sufficient molecular features for a diagnosis of MPNST even in the absence of high-grade histologic features (Figure 1C).